East Somerset Research Consortium, West Coker, Somerset.
Br J Gen Pract. 2009 Aug;59(565):590-4. doi: 10.3399/bjgp09X453800. Epub 2009 Jul 15.
The ageing population is taking an increasing number of both prescribed and non-prescribed medication. Little is known of the potential for adverse drug reactions between these. Warfarin is a commonly prescribed medication, well known for its potential to cause serious adverse reactions in combination with many prescription medicines. It has been suggested that herbal medicines such as garlic, either as a dietary supplement or in cooking, may also interact with warfarin, resulting in poor international normalised ratio (INR) control.
To determine whether, for patients who take garlic as well as warfarin, the proportion of the INR tests in range is lower than in comparable patients who do not take garlic.
Retrospective study of patients taking prescribed warfarin.
Primary care practices in Somerset and Devon.
Three controls (not taking garlic) matched for age, sex, and general practice were compared with each patient self-reporting taking garlic as a supplement. INR results were assessed for the preceding 12 months. Potentially confounding factors were considered, for example diabetes mellitus; all prescribed medication; any bleeding episodes.
No evidence was found to suggest that garlic consumption either as a supplement or in cooking is associated with more frequent haemorrhagic complications or less control of INR. Poor INR control may, however, be associated with taking larger numbers of prescription medicines, particularly during prescription changes.
Further research would be warranted into whether increased INR monitoring is needed when drug changes are made. These data render clinically significant interactions between warfarin and garlic intake unlikely.
随着人口老龄化,越来越多的人同时服用处方药和非处方药。但我们对这些药物之间可能产生的不良反应知之甚少。华法林是一种常用的处方药,众所周知,它与许多处方药合用时可能会引起严重的不良反应。有人认为,大蒜等草药,无论是作为膳食补充剂还是在烹饪中使用,也可能与华法林相互作用,导致国际标准化比值(INR)控制不佳。
确定同时服用大蒜和华法林的患者的 INR 检测结果在目标范围内的比例是否低于不服用大蒜的可比患者。
服用处方华法林的患者的回顾性研究。
萨默塞特郡和德文郡的初级保健诊所。
将每位自我报告服用大蒜作为补充剂的患者与年龄、性别和一般实践相匹配的 3 名对照(未服用大蒜)进行比较。评估了前 12 个月的 INR 结果。考虑了可能的混杂因素,例如糖尿病;所有处方药;任何出血事件。
没有证据表明大蒜的摄入(无论是作为补充剂还是在烹饪中)与更频繁的出血并发症或 INR 控制更差有关。然而,INR 控制不佳可能与服用更多种类的处方药有关,尤其是在处方更改期间。
需要进一步研究在进行药物更改时是否需要增加 INR 监测。这些数据表明华法林和大蒜摄入之间不太可能存在临床显著的相互作用。